Skip to main content

Advertisement

SpringerLink
Log in

Overactive bladder syndrome presentations at the 31st International Urogynecological Association Annual Meeting

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

There were 586 abstracts presented at the 31st Annual Meeting of the International Urogynecological Association in Athens, Greece, in September 2006. Many of these abstracts focused on the common condition of overactive bladder syndrome. The results of large multicenter industry-sponsored trials such as MATRIX, STAR, and SUNRISE were presented. Smaller trials of new treatments, including pudendal nerve stimulation and botulinum toxin A injection, were presented. A pair of studies addressed the importance of anatomic correction of pelvic organ prolapse in the treatment of overactive bladder syndrome. Nineteen abstracts are reviewed here.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vella MV, Robinson DR, Cardozo LC, et al.: Still an unreliable witness? Does clinical assessment reflect patient’s perception of the overactive bladder? [abstract 15]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):66.

    Google Scholar 

  2. Kelleher CJ, Basra RK, Cortes EJ: The Bladder Self-Assessment Questionnaire (BSAQ): a new screening tool for patients with lower urinary tract symptoms [abstract 19]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):68.

    Google Scholar 

  3. Miller JR, Botros SM, Sand PK, et al.: Urgency on bladder palpation as a predictor of detrusor overactivity [abstract 16]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):67.

    Google Scholar 

  4. Basra R, Spiteri M, Kelleher C, Khullar V: Position of bladder sensation during filling changes according to urodynamics diagnosis [abstract 130]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):134.

    Google Scholar 

  5. Rahmanou P, Rajah M, Grogono J, V Khullar V: Bladder contractility in women and urodynamic diagnosis [abstract 18]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):68.

    Google Scholar 

  6. Kelleher CJ, Sand PK, Dahl N: Evaluation of quality of life and safety in a large community-base population with overactive bladder [abstract 119]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):127.

    Google Scholar 

  7. del Jong M, Slieker M, Vierhout ME: Pelvic floor dysfunction and quality of life in relation to sexual activity and satisfaction [abstract 20]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):69.

    Google Scholar 

  8. Zahariou A, Georgantzis D, Karagiannis G, et al.: Sexuality alterations in women with urgency or urge incontinence [abstract 121]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):129.

    Google Scholar 

  9. Sand PK, Kelleher CJ, Pizzi L, Dahl N: Effect of treatment for overactive bladder on work productivity [abstract 114]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):125.

    PubMed  Google Scholar 

  10. Sand PK, Kelleher CJ, Dahl N: Nocturia in a large community population treated with transdermal oxbutynin [abstract 116]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):126.

    Google Scholar 

  11. Chapple C, Breza J, Halaska M, et al.: Patients treated with solifenacin exhibited greater reductions in incontinence episodes and pad use than tolterodine ER prior to a dose increase option in a randomized double-blind overactive bladder trial (the STAR study) [abstract 50]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):87.

    Google Scholar 

  12. Chapple C, Everaert K, Madsen M, et al.: Treatment outcomes in the STAR study for patients self selecting to remain on original dose: comparison of solifenacin 5 MG and tolterodine ER 4 MG] [abstract 51]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):88.

    Google Scholar 

  13. Cardozo L, Nagy G, Kiss L, et al.: Solifenacin in the treatment of urgency symptoms of overactive bladder in a flexible dose, placebo controlled trial (the SUNRISE study) [abstract 52]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):88.

    Google Scholar 

  14. Glavind K, Hill S, Kawakami F, K L’Heritier L: Efficacy and tolerability of darifenacin in female patients with overactive bladder (OAB): a 2-year, open-label extension study [abstract 117]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):127.

    Google Scholar 

  15. Olshansky B, Foote J, Arguinzoniz M, et al.: Cardiovascular safety of darifenacin and tolterodine in patients with overactive bladder (OAB) [abstract 49]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):86.

    Google Scholar 

  16. Aguirre OA: Acute pudendal nerve stimulation improves cystometric volumes in urge incontinent patients [abstract 113]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):125.

    Google Scholar 

  17. Karsenty G, Elzayat E, St. Denis B, et al.: Safety of Botulinum toxin type A (BTA) injections in the trigone to treat overactive bladder (OAB): a pilot study [abstract 124]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):131.

    Google Scholar 

  18. Salvatore S, Serati M, Zanfra M, et al.: Efficacy of anti muscarinics in women with anterior vaginal wall prolapse: is it the same? [abstract 115]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):126.

    Google Scholar 

  19. Digesu GA, Benatti C, Maruccia S, et al.: Do overactive bladder symptoms improve after anterior vaginal wall prolapse repair? [abstract 149]. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(Suppl 8):144.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Evanston Continence Center, Evanston Northwestern Healthcare, 1000 Central Street, Suite 730, Evanston, IL, 60201, USA

    Jay-James R. Miller

Authors
  1. Jay-James R. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter K. Sand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jay-James R. Miller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, JJ.R., Sand, P.K. Overactive bladder syndrome presentations at the 31st International Urogynecological Association Annual Meeting. Curr Urol Rep 8, 435–440 (2007). https://doi.org/10.1007/s11934-007-0045-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-007-0045-1

Keywords

Search

Navigation